Page last updated: 2024-08-24

bendamustine and Breast Neoplasms

bendamustine has been researched along with Breast Neoplasms in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's3 (100.00)2.80

Authors

AuthorsStudies
Abd El-Karim, SS; Ahmed, NS; Anwar, MM; El-Hallouty, SM; Srour, AM1
He, L; Jia, JJ; Luo, L; Wang, G; Zheng, S; Zhong, Q; Zhong, X1
Chen, C; He, L; Hu, M; Jia, J; Li, H; Wang, G; Xu, L; Yin, H; Zhang, W; Zheng, S; Zhong, Q1

Other Studies

3 other study(ies) available for bendamustine and Breast Neoplasms

ArticleYear
Design, synthesis, biological evaluation, QSAR analysis and molecular modelling of new thiazol-benzimidazoles as EGFR inhibitors.
    Bioorganic & medicinal chemistry, 2020, 09-15, Volume: 28, Issue:18

    Topics: Antineoplastic Agents; Apoptosis; Benzimidazoles; Breast Neoplasms; Cell Proliferation; Drug Screening Assays, Antitumor; ErbB Receptors; Erlotinib Hydrochloride; Female; Humans; MCF-7 Cells; Molecular Docking Simulation; Protein Kinase Inhibitors; Quantitative Structure-Activity Relationship; Thiazoles

2020
Synthesis and anticancer activity evaluation of naphthalene-substituted triazole spirodienones.
    European journal of medicinal chemistry, 2021, Mar-05, Volume: 213

    Topics: Animals; Antineoplastic Agents; Apoptosis; Breast Neoplasms; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Computer Simulation; Drug Screening Assays, Antitumor; Female; Humans; Male; Mice; Naphthalenes; Structure-Activity Relationship; Triazoles

2021
Design, synthesis, and evaluation of a novel series of mono-indolylbenzoquinones derivatives for the potential treatment of breast cancer.
    European journal of medicinal chemistry, 2022, Jul-05, Volume: 237

    Topics: Animals; Antineoplastic Agents; Apoptosis; Breast Neoplasms; Cell Line, Tumor; Cell Proliferation; Drug Screening Assays, Antitumor; Female; Humans; Mice; Tumor Suppressor Protein p53

2022